Related Experiment Video
Updated: Aug 2, 2026

Ascending Aortic Constriction in Rats for Creation of Pressure Overload Cardiac Hypertrophy Model
Published on: June 29, 2014
Cardiac renin-angiotensin system: role in development of pressure-overload hypertrophy
1Charles A Dana Research Institute, Boston, Massachusetts, USA.
Insights
The cardiac renin-angiotensin system plays a key role in pressure-overload hypertrophy and heart failure. Angiotensin II (Ang II) directly impairs diastolic function, but angiotensin-converting enzyme (ACE) inhibition improves it.
Area of Science:
- Cardiology
- Renal Physiology
Background:
- The cardiac renin-angiotensin system (cRAS) is implicated in pressure-overload-induced cardiac hypertrophy and failure.
- Angiotensin II (Ang II) may directly affect diastolic function in hypertrophied hearts.
Purpose of the Study:
- To review studies on the role of cRAS in cardiac hypertrophy and failure.
- To investigate the effects of angiotensin-converting enzyme (ACE) inhibition on cardiac function.
Main Methods:
- Utilized the aortic banded rat model of cardiac hypertrophy.
- Assessed intracardiac Ang II levels, diastolic function, and neurohormonal markers.
- Evaluated the impact of acute intracardiac ACE inhibition in patients with aortic stenosis.
Main Results:
- Intracardiac Ang I to Ang II conversion is increased in hypertrophied hearts.
- Ang II directly impairs diastolic relaxation and tone.
- ACE inhibition improved diastolic function in patients and reduced LV diastolic pressure in rats.
- ACE inhibition normalized elevated noradrenaline levels and reduced cardiac dimensions.
Conclusions:
- The cardiac renin-angiotensin system is a critical mediator of pressure-overload hypertrophy and cardiac dysfunction.
- Targeting intracardiac ACE activity offers a therapeutic strategy for diastolic dysfunction and heart failure.
Abstract:
Recent studies are reviewed dealing with the putative roles of the cardiac renin-angiotensin system in the development of pressure-overload hypertrophy and the subsequent transition from adaptive hypertrophy to diastolic dysfunction, impaired systolic function and cardiac failure. The results of these studies, which employed the aortic banded rat model of cardiac hypertrophy, indicate that the intracardiac conversion of angiotensin I (Ang I) to angiotensin II (Ang II) is significantly increase in hypertrophied hearts compared with hearts from age-matched, sham-operated controls, and that Ang II may have a direct effect of slowing relaxation and altering diastolic tone in the hypertrophied heart. Furthermore, in patients with aortic stenosis and severe baseline abnormalities of diastolic relaxation and filling, acute intracardiac angiotensin-converting enzyme (ACE) inhibition, totally in the absence of any systemic effect on neurohormones, improved diastolic function. ACE inhibition was found to reduce net ACE activity and to increase plasma renin activity in aortic banded animals compared with untreated banded controls. There was also a trend for circulating noradrenaline levels to be increased at this stage of transition to failure in the untreated banded animals but ACE inhibition tended to restore the levels back to normal. In ACE inhibitor-treated animals, left ventricular (LV) diastolic pressure was significantly reduced, despite the persistent elevation of systolic pressure, but not yet restored completely to normal. In untreated, banded animals the transition to cardiac failure was evidenced as an increase in both systolic and diastolic dimensions with a reduction in fractional shortening.(ABSTRACT TRUNCATED AT 250 WORDS)
Related Concept Videos
Hormonal Regulation
Hypertension and Regulation of Blood Pressure
Pathophysiology of Heart Failure
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Heart Failure II: Pathophysiology
Hypertension II: Pathophysiology

